CO-IMPACT Expert Network
International Group of Investigators
CO-IMPACT 1
Impact of PSMA PET CT/MRI at first diagnosis on outcomes in unfavourable intermediate- and high-risk prostate cancer.
Principal Investigators (PIs):
Dr. Simon K.B. Spohn
Department of Radiation Oncology, Medical Center – University of Freiburg, Freiburg, Germany
simon.spohn@uniklinik-freiburg.deDr. Marco Vogel
Department of Radiation Oncology, Technical University Munich, Munich, Germany
marco.vogel@tum.deDr. Stephanie G.C. Kroeze
Radiation Oncology Center Mittelland, Canton Hospital Aarau, Aarau, Switzerland
stephanie.thoma@ksa.chDr. Giulia Marvaso
Dipartimeno di Oncologia ed Onco-ematologia presso Università degli Studi di Milano, Milano, Italy
Giulia.Marvaso@ieo.itCO-IMPACT 2
Impact of PSMA PET CT/MR imaging for salvage radiotherapy guidance in prostate cancer patients with recurrent or persistent PSA after primary prostatectomy.
Principal Investigators (PIs):
Dr. Nina-Sophie Schmidt-Hegemann
Department of Radiation Oncology, University Munich (LMU), Munich, Germany
Nina-Sophie.Hegemann@med.uni-muenchen.deDr. Shankar Siva
Department of Radiation Oncology, Peter MacCallum Cancer Center, Melbourne, Australia
Shankar.Siva@petermac.orgDr. Mohamed Shelan
Department of Radiation Oncology, University of Bern, Bern, Switzerland
Mohamed.Shelan@insel.chCO-IMPACT 3
Impact of PSMA PET CT/MR imaging in prostate cancer patients with recurrent PSA after primary radiotherapy.
Principal Investigators (PIs):
Dr. Tobias Hoelscher
Department of Radiation Oncology, University of Dresden, Dresden, Germany
Tobias.Hoelscher@uniklinikum-dresden.deDr. Jan Peeken
Department of Radiation Oncology, Technical University Munich, Munich, Germany
jan.peeken@tum.deCO-IMPACT 4
Impact of PSMA PET CT/MR imaging in castration-resistant prostate cancer patients with radiotherapy due to oligoprogressive disease.
Principal Investigators (PIs):
Dr. Matthias Guckenberger
Department of Radiation Oncology, University of Zürich, Switzerland
Matthias.Guckenberger@usz.chDr. Thomas Zilli
IOSI - Oncology Institute of Southern Switzerland, EOC, Switzerland
Thomas.Zilli@eoc.chDr. S. Gillessen
IOSI - Oncology Institute of Southern Switzerland, EOC, Switzerland
silke.gillessen.sommer@usi.ch